FENNEC PHARMACEUTICALS INC (FRX.CA) Stock Analyst Ratings
TSX:FRX - Toronto Stock Exchange - CA31447P1009 - Common Stock - Currency: CAD
ChartMill assigns a Buy % Consensus number of 85% to FRX.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.1. This target is 111.56% above the current price.
FRX.CA was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about FRX.CA.
In the previous month the buy percentage consensus was at a similar level.
FRX.CA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-23 | Cantor Fitzgerald Securities | Upgrade | Overweight |
| 2021-06-03 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-21 | Craig-Hallum | Initiate | Buy |
| 2021-04-19 | Maxim Group | Initiate | Buy |